See if the news is as good as the presentation last week. You can't keep getting tremendous news and not have the stock move higher. Sooner or later someone will have to recognize the value of this company.
This has to move to new highs of $30+
The stock just keeps trending lower and lower. It's quite apparent that there is no partnership lining up and no large drug companies interested in ARWRs' work yet. Maybe in a year or two, but not now. So, it's obvious the street is preparing for a secondary, which will send the stock back into the low 3's or hi 2's. The shorts appear to have this one right for at least the next year or so.
Last week's announcement of Pfizer and Wave teaming up on RNAi technology should put a rush on someone partnering with ARWR. I don't think there's any doubt this now has to happen quickly as the big companies don't want to get shout out of this breakthrough technology.
She said that on Fast Money after Gild earnings. She rattled off a couple areas where she said GILD will be looking to make a purchase.
Just what were you waiting to hear? You think he was going to say oh, and by the way, we have three companies that we're in discussions with who want to partner with us? Get real. He can't say a thing and he didn't. Like I said, nothing comes this easy.....shorts....
M&A activity and partnerships have been picking up dramatically in the last week or two. I'm sure ARWR has to be a prime target of many.
He's started to created some very positive momentum over the past few months. To do something to hurt investors at this point would set him and the stock back severely. Something tells me he won't let that happen and we'll get some more positives from the conference call.
This looks way to easy for the shorts and I believe we are going to get some kind of very positive financing or partnership that nobody will be expecting. Seen this kind of set-up too many times. It's never this easy.....shorts.....
Henry, unfortunately I am like you. I listened to the pumpers when I should have been listening to the market. This stock is full of shorts and they do their homework and are right most of the time. Although this story sounds good, so do most biotech stories. You hit the nail right on the head; where are the big Pharma companies? Nobody is interested and there will be no partnership before one of these drugs is at least in Phase 3. So, I applaud your post and thank you for the insight. Nothing happening here. Thanks.....
cod, since the company just posted the position for a person to consummate the partnership, it's clear nothing is going to happen for at least 6 months to a year. Secondly, the stock would not be in full collapse mode if there were even a hint of a partnership. Finally, I get the 2 or 3 price range because it's just a simple fact that with all this negativity surrounding the stock, it has to return to it's low or even lower.
Pixel is owned bu Undertone, a subsidiary of PERI. Plus, they just did a deal with FB. This should be a $10 stock without even trying.
With at least 3 conferences to present at this month, one has to wonder if we won't be getting data to boost interest and possibly raise a partner or two. You can almost feel it coming.....
I guess the money issue will be in full focus as this stock is getting pummeled in a great market. One can only come up with one explanation, and that's the money issue. It looks like this CEO won't be able to keep his word when he said they don't need cash in a hurry and they won't be affecting shareholders if they do raise cash. Shorts are telling us he will likely be going back on his word tonight.
Agree. People need to see what he has to say as he's called this stock correctly almost from day one. Jeffey Pee Works, the resident IV board pumper, disagrees with Amedeus but Jeffty has been so wrong on VHC it's a wonder if anyone pays any attention to him anymore or not.
thanks crisp, I got caught up in all the positive comments by the pumpers. I should have known something was wrong as the stock is down almost every single day. I didn't realize we had now been passed by ALNY and others. Worse yet, no partnership possible until late 2017? They can't possibly survive that long. This now looks like a good short given your insight. Appreciate the help. I knew this looked too good to be true and was wondering why the smart money is selling and shorting. Now I know. Thanks again.